EP3448874A4
(en )
2020-04-22
Compositions for the treatment of disease
EP3448987A4
(en )
2020-05-27
Compositions for the treatment of disease
EP3615040A4
(en )
2020-12-16
Hair-treatment compositions
EP3675859A4
(en )
2021-06-30
Compounds, compositions, and methods for the treatment of disease
TWI799397B
(en )
2023-04-21
Compositions for the treatment of hypertension
EP3538189A4
(en )
2020-04-22
Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions
PT3573620T
(en )
2023-03-20
Compositions for the treatment of hypertension
EP3634426A4
(en )
2021-04-07
Compositions for the treatment of fibrosis
AU2018302248A1
(en )
2020-01-30
Compositions for treating stress-related disorders
EP3522873A4
(en )
2020-07-29
Compositions and methods for the treatment of xerostomia
EP3288636A4
(en )
2019-01-16
Compositions for the treatment of epistaxis
HUE065955T2
(en )
2024-07-28
Compositions for the treatment of vulvodynia
EP3426671A4
(en )
2019-11-20
Compounds and compositions for the treatment of infections
EP3813872A4
(en )
2022-03-23
Compositions for the treatment of skin conditions
EP3294294A4
(en )
2019-01-02
Compositions and methods for the treatment or prevention of pulmonary hypertension
ZA202006591B
(en )
2021-08-25
Compositions for the treatment of hypertension
HK40116862A
(en )
2025-05-02
Compositions for the treatment of hypertension
HK40106299A
(en )
2024-09-06
Compositions for the treatment of hypertension
HK40092202A
(en )
2023-12-22
Compositions for the treatment of hypertension
EP3576749B8
(en )
2025-08-27
Flavonoid compositions for treating hypertension
IL265242B
(en )
2021-09-30
Compositions for the treatment of hypertension and/or fibrosis
HK40091518A
(en )
2023-12-08
Composition for the treatment of veisalgia
EP3285763A4
(en )
2018-12-05
Compositions for the treatment of cancer
HK40015207A
(en )
2020-08-28
Compositions for the treatment of hypertension
HK40107870A
(en )
2024-11-01
Esketamine for the treatment of depression